Evaluating the 6-Minute Stepper Test for Predicting Mortality in COPD

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the predictive properties of the 6-Minute Stepper Test for mortality in individuals with Chronic Obstructive Pulmonary Disease (COPD). It will analyze medical records of patients referred for pulmonary rehabilitation at the ADIR Association in France from 2015 to 2023. The study will collect various demographic and health-related data, including performance metrics from the stepper test, to determine the test's effectiveness in predicting 2-year and 5-year mortality rates. A receiver operator curve analysis will be conducted to identify the optimal threshold for predicting all-cause mortality based on test performance.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age \> 18 years;
* Covered by a social security scheme;
* COPD (all stages);
* Referred for pulmonary rehabilitation;
* Completed a 6-Minute Stepper Test at the start of their program.

Non-inclusion Criteria:

* Patients under guardianship or legal supervision;
* Pregnant or breastfeeding women.

Exclusion Criteria:

* Not applicable.

Where it's running

• ADIR Association
  Rouen, France Recruiting

Study contacts

• Principal investigator: Tristan Bonnevie, PhD — ADIR Association
• Study coordinator: Tristan Bonnevie, PhD
• Email: t.bonnevie@adir-hautenormandie.com
• Phone: +33232592970

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer

  This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.

  Recruiting Phase 2 AeroRx Therapeutics Inc. · London and 1 other locations · NCT07896252

• Cognitive load and inhaler technique in COPD

  This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.

  Recruiting Spitalul Clinic de Boli Infecțioase și Pneumoftiziologie Dr. Victor Babeș Timișoara · Timișoara, Timiș County · NCT07786220

• Balance training after pulmonary rehab for COPD to help steadiness and reduce falls

  A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.

  Recruiting at 3 sites Teesside University · Middlesbrough and 2 other locations · NCT07750821

• Continuous vs High-Intensity Interval Exercise in COPD

  This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.

  Recruiting George Papanicolaou Hospital · Thessaloniki, Exohi · NCT07707271

• Biomarker clues for COPD, IPF, and lung cancer

  This study tests whether inflammation, immune, genetic, and epigenetic markers at enrollment can explain how COPD, IPF, or lung cancer present and behave, in order to see if these markers can predict outcomes over a year.

  Recruiting Fondazione Don Carlo Gnocchi ETS · Milan, Milan · NCT07707245

• HRS-9821 Inhalation Suspension for COPD: Safety and Dose Finding in Adults

  This study tests whether HRS-9821 inhalation can be safely taken and help people with moderate to severe COPD, and aims to find a reasonable dose.

  Recruiting Phase 2 Guangdong Hengrui Pharmaceutical Co., Ltd · Shanghai, Shanghai Municipality · NCT07640451

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.